Banque Pictet & Cie Sa Vaxcyte, Inc. Transaction History
Banque Pictet & Cie Sa
- $14.9 Billion
- Q4 2024
A detailed history of Banque Pictet & Cie Sa transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Banque Pictet & Cie Sa holds 59,315 shares of PCVX stock, worth $5.28 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
59,315
Previous 64,772
8.42%
Holding current value
$5.28 Million
Previous $7.4 Million
34.35%
% of portfolio
0.03%
Previous 0.06%
Shares
4 transactions
Others Institutions Holding PCVX
# of Institutions
355Shares Held
123MCall Options Held
772KPut Options Held
430K-
Vanguard Group Inc Valley Forge, PA11.4MShares$1.02 Billion0.02% of portfolio
-
Janus Henderson Group PLC London, X010.9MShares$972 Million0.67% of portfolio
-
Black Rock Inc. New York, NY9.94MShares$885 Million0.02% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.69MShares$774 Million13.83% of portfolio
-
Capital Research Global Investors Los Angeles, CA4.9MShares$436 Million0.12% of portfolio
About Vaxcyte, Inc.
- Ticker PCVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,315,100
- Market Cap $5.28B
- Description
- Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...